[ad_1]
Strategists at UBS led by Matthew Mish say corporate debt will benefit when fund flows begin to shift.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...